CPX-351 in Down syndrome–associated myeloid leukemia: results and prognostic factors from the phase 3 ML-DS 2018 trial

Journal:
Blood
Published:
Affiliations:
10
Authors:
22
Institutions Authors Share
Goethe University Frankfurt (GU), Germany
14.000000
14.000000
0.64
Pediatric Research Network, Germany
2.000000
0.09
Hannover Medical School (MHH), Germany
1.000000
0.05
Princess Maxima Centre for Pediatric Oncology (PMC), Netherlands
1.000000
0.05
Ghent University Hospital, Belgium
1.000000
0.05
University Children's Hospital of Zurich, Switzerland
1.000000
0.05
Jagiellonian University (UJ), Poland
1.000000
0.05
St. Anna Children's Hospital, Austria
0.666667
0.03
Medical University of Vienna (MUW), Austria
0.333333
0.02